secwatch / observer
8-K filed Jan 02, 2026 23:59 UTC ticker DCOY CIK 0001615219
other confidence high sentiment neutral materiality 0.20

Salarius shareholders re-elect directors, approve executive compensation, ratify EY as auditor

Decoy Therapeutics Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001615219-26-000003
form_type
8-K
ticker
DCOY
cik
0001615219
company_name
Decoy Therapeutics Inc.
filed_at
2026-01-02T23:59:59+00:00
discovered_at
2026-05-14T18:02:35.647085+00:00
generated_at
2026-05-16T11:48:51.994448+00:00
sec_items
["5.07"]
event_type
other
sentiment
neutral
materiality_score
0.2
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001615219-26-000003
json_url
https://secwatch.observer/filing/0001615219-26-000003.json
markdown_url
https://secwatch.observer/filing/0001615219-26-000003.md
text_url
https://secwatch.observer/filing/0001615219-26-000003.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/0001615219-26-000003-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1615219/000161521926000003/flks-20251231.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
Source: SEC EDGAR
accession 0001615219-26-000003

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.